Genomic risk classification by the 70-gene signature and 21-gene assay in African American early-stage breast cancer patients.

e12568Background: Genomic risk of recurrence assays provide prognostic information that aids treatment recommendations for patients with early breast cancer (EBC). The 70-gene signature (MammaPrint...